ストックスクリーナーアプリを入手
2.22
0.45%
-0.010
アフターアワーズ：
2.22
前日終値:
$2.23
開ける：
$2.16
24時間の取引高:
6,811
Relative Volume:
0.12
時価総額：
$6.70M
収益：
$4.88M
当期純損益:
$-3.66M
株価収益率:
-1.4467
EPS:
-1.5345
ネットキャッシュフロー:
$-2.80M
1週間 パフォーマンス:
+2.78%
1か月 パフォーマンス:
-13.62%
6か月 パフォーマンス:
-25.25%
1年 パフォーマンス:
-70.57%
1日の値動き範囲:
$2.1342
$2.24
1週間の範囲:
$2.1342
$2.29
52週間の値動き範囲:
$2.11
$7.92
Biomerica Inc Stock (BMRA) Company Profile
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.22 | 6.73M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
112.19 | 197.00B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
372.66 | 144.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
97.58 | 126.27B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
75.72 | 113.12B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.92 | 45.83B | 6.07B | 1.06B | 799.60M | 1.8527 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Vietnam Approves Biomerica's Ez Detect?? for Nationwide Distribution - marketscreener.com
Biomerica (BMRA) Expands in Vietnam with Approval of EZ Detect T - GuruFocus
Vietnam approves Biomerica’s at-home colorectal cancer screening test - Investing.com
Biomerica Receives Approval for EZ Detect™ Colorectal Disease Test in Vietnam, Expanding Access to At-Home Cancer Screening - Quiver Quantitative
At-home colon cancer test EZ Detect cleared for nationwide use in Vietnam - Stock Titan
Vietnam Approves Biomerica's EZ Detect for Nationwide Distribution - Bitget
Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Decline in Short Interest - Defense World
What is the next catalyst for Biomerica Inc.Exit Point & Free Long-Term Investment Growth Plans - mfd.ru
Is Biomerica Inc. stock supported by strong fundamentalsWeekly Market Report & Fast Exit and Entry Strategy Plans - mfd.ru
Why analysts upgrade Biomerica Inc. stockJuly 2025 Setups & Long-Term Capital Growth Strategies - mfd.ru
Is Biomerica Inc. a good stock for dollar cost averaging2025 Top Gainers & Precise Entry and Exit Recommendations - mfd.ru
Growth Review: Is Biomerica Inc. being accumulated by smart moneyEarnings Summary Report & Fast Moving Stock Trade Plans - mfd.ru
Sell Signal: Is Biomerica Inc stock a value trapWeekly Stock Recap & Comprehensive Market Scan Reports - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
What are the future prospects of Biomerica IncWeekly Gains Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Trend Recap: Is Biomerica Inc being accumulated by smart moneyQuarterly Profit Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Short Covering: What is the next catalyst for Biomerica IncDip Buying & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Should value investors consider Biomerica Inc2025 Trading Volume Trends & Free Verified High Yield Trade Plans - baoquankhu1.vn
Short Covering: Is Biomerica Inc stock risky to hold nowWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Macro Review: Is Biomerica Inc backed by strong institutional buying2025 Breakouts & Breakdowns & Technical Pattern Alert System - baoquankhu1.vn
US-based Biomerica reports net sales of USD 1.21M in Q2 2026 - Medical Buyer
Biomerica Reports Second Quarter Fiscal 2026 Financial Results - The Manila Times
Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition - TradingView — Track All Markets
BIOMERICA INC SEC 10-Q Report - TradingView
Medicare sets $300 price for IBS test as Biomerica expands AI diet tool - Stock Titan
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Expands By 123.2% - Defense World
Bullfrog AI Holdings, Inc. (NASDAQ:BFRGW) Short Interest Update - Defense World
Earnings Miss: Is Biomerica Inc stock risky to hold nowPortfolio Update Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
How interest rate cuts could boost Biomerica Inc. stockPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Will Biomerica Inc. stock maintain dividend yield2025 Key Highlights & Expert Approved Momentum Ideas - Улправда
Is Biomerica Inc. stock safe for conservative investorsBuy Signal & Reliable Breakout Forecasts - Улправда
Can Captivision Inc. stock deliver strong Q4 earningsTreasury Yields & Daily Entry Point Trade Alerts - Улправда
How Biomerica Inc. stock responds to policy changesInsider Selling & Weekly Setup with ROI Potential - Улправда
How supply chain issues affect Rain Enhancement Technologies Holdco Inc. Equity Warrant stockQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - Улправда
Why CRVS stock is rated strong buyWeekly Gains Summary & Fast Moving Market Watchlists - Улправда
Will Bulten AB (publ) (3FB) stock return to pre crash levels2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Targets Report: Why Adams Natural Resources Fund Inc. stock remains stableWeekly Investment Recap & Risk Controlled Stock Alerts - Улправда
Is The Vita Coco Company Inc. stock trading at a premium valuationIPO Watch & Safe Capital Growth Plans - Улправда
Zodiac Energy Limited (ZODIAC) Signs Major DealGap Up/Gap Down Analysis & Budget Friendly Trading Strategies - bollywoodhelpline.com
Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test - MSN
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Biomerica stock soars after Medicare sets $300 payment rate for IBS test - Investing.com Australia
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 - Investing.com Nigeria
Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade
Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com
Biomerica stock soars after Medicare sets $300 payment rate for IBS test By Investing.com - Investing.com Nigeria
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - The Manila Times
Biomerica announces CMS Medicare payment rate of $300 for revolutionary Infoods® IBS test - marketscreener.com
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
1.02%
0.73%
大文字化:
|
ボリューム (24 時間):